 Shares of Quanterix Corp. rallied nearly 10 in the extended session Monday after the life-sciences company said the Food and Drug Administration has issued an emergency use authorization for the companys SARS-CoV-2 antigen test. The test is intended for use with nasopharyngeal samples in people suspected of being ill with COVID-19, the company said. 